中图分类号：
R473.5
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] GOLOMB BA,CHAN VT,DENENBERG JO,et al.Risk marker associations with venous thrombotic events:a cross-sectional analysis[J].BMJ Open,2014,4(3):e003208.
[2] 中华医学会骨科学分会.中国骨科大手术静脉血栓栓塞症预防指南[J].中华骨科杂志,2016,36(2):65-71.
[3] 徐园,王晓杰,陈亚萍,等.建立住院患者静脉血栓栓塞症上报系统内容的研究[J].中华护理杂志,2016,51(8):956-959.
[4] HINOJOSA CA,OLIVARES-CRUZ S,LAPARRA-ESCARENO H,et al.Impact of optimal anticoagulation therapy on chronic venous ulcer healing in thrombophilic patients with post-thrombotic syndrome[J].J Wound Care,2016,25(12):756-763.
[5] BARBAR S,NOVENTA F,ROSSETTO V,et al.A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism:the Padua Prediction Score[J].J Thromb Haemost,2010,8(11):2450-2457.
[6] 周玉杰,杨士伟.美国胸科医师协会第九版抗栓治疗及血栓预防指南静脉血栓栓塞性疾病最新进展[J].中国医学前沿杂志(电子版),2013,5(3):33-37.
[7] 丁颖,汤珏瑶,郭梅.基于Autar量表的围生期深静脉血栓形成高危因素评估表的设计与应用[J].护理学杂志,2016,31(14):23-25.
[8] SAMAMA MM,DAHL OE,MISMETTIP Q,et al.An electronic tool for venous thromboembolism prevention in medical and surgical patients[J].Haematol,2006,91(1):64-70.
[9] CATTERICJ D,HUNT BJ.Impact of the national venous thromboembolism risk assessment tool in secondary care in England:retrospective population-based database study[J].Blood Coagul Fibrinolysis,2014,25(6):571-576.
[10] VARDI M,GHANEM-ZOUBI NO,ZIDAN R,et al.Venous thromboembolism and the utility of the Padua Prediction Score in patients with sepsis admitted to internal medicine departments[J].J Thromb Haemost,2013,11(3):467-473.
[11] NENDAZ M,SPIRK D,KUCHER N,et al.Multicentre validation of the Geneva Risk Score for hospitalised medical patients at risk of venous thromboembolism.Explicit Assessment of Thromboembolic Risk and Prophylaxis for Medical Patients in Switzerland (ESTIMATE)[J].J Thromb Haemost,2014,111(3):531-538.
[12] CASTELLUCCI LA,CAMERON C,LE GAL G,et al.Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism:systematic review and network meta-analysis[J].BMJ,2013,347(7924):5133.
[13] HILL J,TREASURE T,Guideline Development Group.Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital:summary of the NICE guideline[J].Heart,2010,96(11):879-882.
[14] CHOI M,HECTOR M.Management of venous thromboembolism for older adults in long-term care facilities[J].J Am Acad Nurse Pract,2012,24(6):335-344.
[15] KAKKOS SK,WARWICK D,NICOLAIDES AN,et al.Combined (mechanical and pharmacological) modalities for the prevention of venous thromboembolism in joint replacement surgery[J].J Bone Joint Surg Br,2012,94(6):729-734.
[16] DI NISIO M,PORRECA E,CANDELORO M,et al.AW.Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy[J].Cochrane Database Syst Rev,2016,12:CD008500.
[17] TESTROOTE M,STIGTER WA,JANSSEN L,et al.Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization[J].Cochrane Database Syst Rev,2014,4:CD006681.
[18] 刘咸罗,钱小星,汤永胜,等.C-反应蛋白作为深静脉血栓形成生物学观察指标的评价[J].中国医疗前沿,2011,6(21):7-8.
[19] BIKDELI B,SHARIF-KASHANI B,SHAHABI P,et al.Comparison of three risk assessment methods for venous thromboembolism prophylaxis[J].Blood Coagul Fibrinolysis,2013,24(2):157-163.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
复旦大学护理科研基金（FNF201648）；复旦大学临床医学与护理学双一流建设（2018-22-40）
{{custom_fund}}
PDF(742 KB)
